EXMceuticals (STU:9OM1) ROCE % : 0.00% (As of Mar. 2021)

View and export this data going back to 2019. Start your Free Trial

What is EXMceuticals ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. EXMceuticals's annualized ROCE % for the quarter that ended in Mar. 2021 was 0.00%.

EXMceuticals ROCE % Historical Data

The historical data trend for EXMceuticals's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

EXMceuticals ROCE % Chart

EXMceuticals Annual Data

Trend

Jun11

Jun12

Jun13

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

ROCE %

Get a 7-Day Free Trial

-288.98

-448.94

-3,142.79

EXMceuticals Quarterly Data
	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21
ROCE %	Get a 7-Day Free Trial															-	-	-	-	-

EXMceuticals ROCE % Calculation

EXMceuticals's annualized ROCE % for the fiscal year that ended in Jun. 2020 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Jun. 2020 )		(A: Jun. 2019 )		(A: Jun. 2020 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Jun. 2020 )		(A: Jun. 2019 )		(A: Jun. 2020 )
	=	-6.143	/	( ( (1.637 - 1.38)	+	(0.82 - 5.434) )	/ 2 )
	=	-6.143	/	( (0.257	+	-4.614)	/ 2 )
	=	-6.143	/	-2.1785
	=	281.98 %

EXMceuticals's ROCE % of for the quarter that ended in Mar. 2021 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Mar. 2021 )		(Q: Dec. 2020 )		(Q: Mar. 2021 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Mar. 2021 )		(Q: Dec. 2020 )		(Q: Mar. 2021 )
	=	-6.412	/	( ( (0.726 - 1.608)	+	(0.847 - 1.918) )	/ 2 )
	=	-6.412	/	( ( -0.882	+	-1.071 )	/ 2 )
	=	-6.412	/	-0.9765
	=	0 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2021) EBIT data.

EXMceuticals (STU:9OM1) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

EXMceuticals ROCE % Related Terms

Thank you for viewing the detailed overview of EXMceuticals's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

EXMceuticals (STU:9OM1) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » EXMceuticals Inc (STU:9OM1) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

421 7th Avenue S.W., 30th Floor, Calgary, AB, CAN, T2P 4K9

Website

http://www.exmceuticals.com

EXMceuticals Inc is a bio-science company that believes in the potential health and wellness benefits of hemp and cannabis. EXM is an emerging player in the market, with ambition and potential to become the suppliers of highest-grade cannabis ingredients. It is creating an industrial-scale, GMP, Pharmaceutical Grade Extraction and Refining facility inside the European Union, near Lisbon Portugal. It has an existing and licensed cannabis R&D facility and pilot refinery in Lisbon Portugal. EXM is targeting the B2B marketplace and will supply pure ingredients and API's to the pharmaceutical, medicinal and wellness industry.

EXMceuticals (STU:9OM1) Headlines

No Headlines